Literature DB >> 31586801

Predictors of vocational status among persons with multiple sclerosis.

Christopher A Povolo1, Mervin Blair2, Swati Mehta3, Heather Rosehart1, Sarah A Morrow4.   

Abstract

BACKGROUND: Multiple Sclerosis (MS) is a common cause of neurological disability in young to middle-aged adults, resulting in physical, psychosocial, and cognitive impairments. Manifestation of these symptoms during crucial work-life years can greatly influence the ability of persons with (PwMS) to retain employment. It is unknown what factors are most important in leading to work disability, and if/how these different factors interact with each other and result in work disability.
OBJECTIVE: To determine significant predictors of vocational status among PwMS using a structural equation modeling approach.
METHODS: A retrospective chart review identified PwMS at an academic tertiary care hospital. The following data was collected: demographics and disease characteristics, vocational status, physical disability status (Expanded Disability Status Scale, EDSS), fine motor function (Nine Hole Peg Test, NHPT), generalized fatigue (Fatigue Severity Scale, FSS), mood and anxiety symptoms (Hospital Anxiety and Depression Scale, HADS) and cognitive function (Symbol Digit Modalities Test, SDMT). An exploratory structural equation model (SEM) was developed to examine the predictive utility of clinical and psychosocial variables on vocational status after controlling for demographic and disease characteristics. The fit of the model to the data was examined using the comparative fit index (CFI), normal fit index (NFI), root-mean-squared error of approximation (RMSEA), and standardized root mean residual (SRMR).
RESULTS: There were 158 PwMS included in the analysis. The final model demonstrated that SDMT (β = 0.16), EDSS (β = -0.33), and HADS-D (β = -0.23) significantly predicted vocational status (ps < 0.05). It explained 37% of the variance and provided a good fit to the data (χ2(11) = 13.01, p > 0.05, SRMR = 0.055, RMSEA = 0.034, NFI = 0.94, CFI = 0.99.
CONCLUSIONS: Physical disability, depressive symptoms, and reduced information processing affect work-related disability and vocational status among PwMS. Interventions targeting these factors should be prioritized by clinicians.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; Depression; Functional Status; Multiple Sclerosis; Structural Equation Model; Vocation

Mesh:

Year:  2019        PMID: 31586801     DOI: 10.1016/j.msard.2019.101411

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  4 in total

1.  Factors associated with employment and expected work retention among persons with multiple sclerosis: findings of a cross-sectional citizen science study.

Authors:  Anja I Lehmann; Stephanie Rodgers; Christian P Kamm; Mathias Mettler; Nina Steinemann; Vladeta Ajdacic-Gross; Marco Kaufmann; Jürg Kesselring; Pasquale Calabrese; Anke Salmen; Claudio Gobbi; Chiara Zecca; Georg F Bauer; Viktor von Wyl
Journal:  J Neurol       Date:  2020-06-11       Impact factor: 4.849

2.  Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review.

Authors:  Abril Oliva Ramirez; Alexander Keenan; Olivia Kalau; Evelyn Worthington; Lucas Cohen; Sumeet Singh
Journal:  BMC Neurol       Date:  2021-12-02       Impact factor: 2.474

3.  Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients.

Authors:  Assunta Bianco; Matteo Lucchini; Rocco Totaro; Roberta Fantozzi; Giovanna De Luca; Sonia Di Lemme; Giorgia Presicce; Luana Evangelista; Valeria Di Tommaso; Roberta Pastorino; Chiara De Fino; Valeria De Arcangelis; Diego Centonze; Massimiliano Mirabella
Journal:  Neurotherapeutics       Date:  2021-09-07       Impact factor: 7.620

4.  The relationship between cognition, education, and employment in multiple sclerosis patients.

Authors:  Devon S Conway; Robert A Bermel; Sarah M Planchon
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.